{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T17:03:27Z","timestamp":1793293407474,"version":"4.5.0"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003009","name":"Science and Technology Development Fund","doi-asserted-by":"publisher","award":["PGSG CALL-2"],"award-info":[{"award-number":["PGSG CALL-2"]}],"id":[{"id":"10.13039\/501100003009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003009","name":"Science and Technology Development Fund","doi-asserted-by":"publisher","award":["48583"],"award-info":[{"award-number":["48583"]}],"id":[{"id":"10.13039\/501100003009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.bioorg.2025.109353","type":"journal-article","created":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T17:16:48Z","timestamp":1765473408000},"page":"109353","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Design and synthesis of new 1,3,4-oxadiazole-1,2,3,4-tetrahydroisoquinoline hybrids as selective COX-2 inhibitors"],"prefix":"10.1016","volume":"168","author":[{"given":"Mai I.","family":"Abo-Elmagd","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona E.","family":"Aboutabl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasha M.","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamilia M.","family":"Amin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aida A.","family":"El-Azzouny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed N.","family":"Aboul-Enein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2025.109353_bb0005","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.molcel.2014.03.030","article-title":"Stress, inflammation, and defense of homeostasis","volume":"54","author":"Chovatiya","year":"2014","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bioorg.2025.109353_bb0010","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.cell.2010.02.029","article-title":"Nonresolving inflammation","volume":"140","author":"Nathan","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.bioorg.2025.109353_bb0015","article-title":"Design and synthesis of novel pyrimidine-pyrazole hybrids with dual anticancer and anti-inflammatory effects targeting BRAFV600E and JNK","volume":"1-21","author":"Abdel-Maksoud","year":"2025","journal-title":"Mol. Divers."},{"key":"10.1016\/j.bioorg.2025.109353_bb0020","first-page":"168","article-title":"Evaluation of the antioxidant, anti-inflammatory, and antitumor properties of grown in Egypt, Egypt","volume":"16","author":"Ibrahim","year":"2017","journal-title":"Pharm. J."},{"key":"10.1016\/j.bioorg.2025.109353_bb0025","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1096\/fasebj.12.12.1063","article-title":"Cyclooxygenase in biology and disease","volume":"12","author":"Dubois","year":"1998","journal-title":"FASEB J."},{"key":"10.1016\/j.bioorg.2025.109353_bb0030","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1146\/annurev.immunol.14.1.397","article-title":"Role of cytokines in rheumatoid arthritis","volume":"14","author":"Feldmann","year":"1996","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.bioorg.2025.109353_bb0035","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1146\/annurev.med.51.1.207","article-title":"Anti-cytokine therapy for rheumatoid arthritis","volume":"51","author":"Maini","year":"2000","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.bioorg.2025.109353_bb0040","first-page":"459","article-title":"Antitumor, antioxidant, and anti-inflammatory activity of spirulina against 7, 12-dimethylbenzanthracene-induced mammary cancer, Egypt","volume":"23","author":"Hamdy","year":"2024","journal-title":"Pharm. J."},{"key":"10.1016\/j.bioorg.2025.109353_bb0045","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/384644a0","article-title":"Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents","volume":"384","author":"Kurumbail","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.bioorg.2025.109353_bb0050","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1016\/j.bmcl.2005.02.035","article-title":"QSAR analyses of conformationally restricted 1, 5-diaryl pyrazoles as selective COX-2 inhibitors: application of connection table representation of ligands","volume":"15","author":"Prasanna","year":"2005","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2025.109353_bb0055","doi-asserted-by":"crossref","first-page":"331","DOI":"10.2174\/138955708783955944","article-title":"Multiple functions of generic drugs: future perspectives of aureolic acid group of anti-cancer antibiotics and non-steroidal anti-inflammatory drugs","volume":"8","author":"Chakraborty","year":"2008","journal-title":"Min. Rev. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109353_bb0060","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0223-5234(01)01197-7","article-title":"Cyclooxygenase inhibitors\u2013current status and future prospects","volume":"36","author":"Dannhardt","year":"2001","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109353_bb0065","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nrd1034","article-title":"The development of COX2 inhibitors","volume":"2","author":"Flower","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioorg.2025.109353_bb0070","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0090-6980(02)00026-6","article-title":"The structures of prostaglandin endoperoxide H synthases-1 and-2","volume":"68","author":"Garavito","year":"2002","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"10.1016\/j.bioorg.2025.109353_bb0075","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1056\/NEJM199906173402407","article-title":"Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs","volume":"340","author":"Wolfe","year":"1999","journal-title":"New Eng. J. Med."},{"key":"10.1016\/j.bioorg.2025.109353_bb0080","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1021\/jm0402059","article-title":"Adverse cardiovascular effects of the coxibs","volume":"48","author":"Dogne","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109353_bb0085","first-page":"255","article-title":"Synthesis, molecular docking, and anti-inflammatory activities of some novel Benzimidazole derivatives as potential Cyclo-oxygenase-2 inhibitors","volume":"67","author":"Elrayess","year":"2024","journal-title":"Egypt. J. Chem."},{"key":"10.1016\/j.bioorg.2025.109353_bb0090","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1172\/JCI27291","article-title":"Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities","volume":"116","author":"Grosser","year":"2006","journal-title":"J. Clin. Inv."},{"key":"10.1016\/j.bioorg.2025.109353_bb0095","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1016\/S0140-6736(06)69667-0","article-title":"The ever growing story of cyclo-oxygenase inhibition","volume":"368","author":"Rodr\u00edguez","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.bioorg.2025.109353_bb0100","doi-asserted-by":"crossref","first-page":"3228","DOI":"10.1073\/pnas.91.8.3228","article-title":"Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic","volume":"91","author":"Masferrer","year":"1994","journal-title":"Proceedings Nat. Academy Sci."},{"key":"10.1016\/j.bioorg.2025.109353_bb0105","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/joim.13505","article-title":"Lessons from 20 years with COX-2 inhibitors: importance of dose\u2013response considerations and fair play in comparative trials","volume":"292","author":"Stiller","year":"2022","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.bioorg.2025.109353_bb0110","first-page":"2224237","article-title":"The prescription patterns and safety profiles of oral non-steroidal anti-inflammatory drugs in China: an 8-year real-life analysis, annals of","volume":"10","author":"Meng","year":"2021","journal-title":"Palliat. Med."},{"key":"10.1016\/j.bioorg.2025.109353_bb0115","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.3390\/molecules22091507","article-title":"COX inhibition profile and molecular docking studies of some 2-(trimethoxyphenyl)-thiazoles","volume":"22","author":"Oniga","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2025.109353_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.104883","article-title":"Design, synthesis, biological evaluation, and computational studies of novel thiazolo-pyrazole hybrids as promising selective COX-2 inhibitors: implementation of apoptotic genes expression for ulcerogenic liability assessment","volume":"111","author":"Marzouk","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.109353_bb0125","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.bioorg.2016.12.008","article-title":"Design, synthesis and biological screening of some novel celecoxib and etoricoxib analogs with promising COX-2 selectivity, anti-inflammatory activity and gastric safety profile","volume":"70","author":"Alsayed","year":"2017","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.109353_bb0130","doi-asserted-by":"crossref","first-page":"5273","DOI":"10.1016\/j.bmc.2003.07.005","article-title":"Design and synthesis of novel celecoxib analogues as selective cyclooxygenase-2 (COX-2) inhibitors: replacement of the sulfonamide pharmacophore by a sulfonylazide bioisostere","volume":"11","author":"Uddin","year":"2003","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109353_bb0135","doi-asserted-by":"crossref","first-page":"4582","DOI":"10.1021\/jm990965x","article-title":"1,3-Diaryl-4,5,6,7-tetrahydro-2H-isoindole derivatives: a new series of potent and selective COX-2 inhibitors in which a sulfonyl group is not a structural requisite","volume":"43","author":"Portevin","year":"2000","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109353_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115724","article-title":"Magic shotgun approach to anti-inflammatory pharmacotherapy: synthesis of novel thienopyrimidine monomers\/heterodimer as dual COX-2 and 15-LOX inhibitors endowed with potent antioxidant activity","volume":"260","author":"Elsayed","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109353_bb0145","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.bioorg.2018.11.030","article-title":"1,4-Dihydroquinazolin-3(2H)-yl benzamide derivatives as anti-inflammatory and analgesic agents with an improved gastric profile: design, synthesis, COX-1\/2 inhibitory activity and molecular docking study","volume":"84","author":"Sakr","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.109353_bb0150","doi-asserted-by":"crossref","first-page":"2200123","DOI":"10.1002\/ardp.202200123","article-title":"Oxadiazole: a highly versatile scaffold in drug discovery","volume":"355","author":"Desai","year":"2022","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.bioorg.2025.109353_bb0155","doi-asserted-by":"crossref","first-page":"2300328","DOI":"10.1002\/ardp.202300328","article-title":"Unveiling the chemistry of 1, 3, 4-oxadiazoles and thiadiazols: a comprehensive review","volume":"357","author":"Gour","year":"2024","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.bioorg.2025.109353_bb0160","doi-asserted-by":"crossref","first-page":"789","DOI":"10.2174\/138955712801264800","article-title":"1, 3, 4-oxadiazole: a biologically active scaffold","volume":"12","author":"Khalilullah","year":"2012","journal-title":"Min. Rev. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109353_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2019.105045","article-title":"Design, synthesis and anticancer evaluation of novel 1, 3-benzodioxoles and 1, 4-benzodioxines","volume":"139","author":"Hassan","year":"2019","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.bioorg.2025.109353_bb0170","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ejmech.2015.06.020","article-title":"Synthesis, characterization, evaluation and molecular dynamics studies of 5, 6\u2013diphenyl\u20131, 2, 4\u2013triazin\u20133 (2H)\u2013one derivatives bearing 5\u2013substituted 1, 3, 4\u2013oxadiazole as potential anti\u2013inflammatory and analgesic agents","volume":"101","author":"Banerjee","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109353_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105068","article-title":"Investigation of indole functionalized pyrazoles and oxadiazoles as anti-inflammatory agents: synthesis, in-vivo, in-vitro and in-silico analysis","volume":"114","author":"Kumar","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.109353_bb0180","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1021\/jm2013248","article-title":"Oxadiazoles in medicinal chemistry","volume":"55","author":"Bostr\u00f6m","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109353_bb0185","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1021\/cr950066q","article-title":"Bioisosterism: a rational approach in drug design","volume":"96","author":"Patani","year":"1996","journal-title":"Chem. Rev."},{"key":"10.1016\/j.bioorg.2025.109353_bb0190","doi-asserted-by":"crossref","first-page":"6171","DOI":"10.1016\/j.bmcl.2008.10.015","article-title":"2-Alkylamino-and alkoxy-substituted 2-amino-1, 3, 4-oxadiazoles\u2014O-alkyl benzohydroxamate esters replacements retain the desired inhibition and selectivity against MEK (MAP ERK kinase)","volume":"18","author":"Warmus","year":"2008","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2025.109353_bb0195","doi-asserted-by":"crossref","first-page":"3798","DOI":"10.1016\/j.ejmech.2009.04.009","article-title":"Fenbufen based 3-[5-(substituted aryl)-1, 3, 4-oxadiazol-2-yl]-1-(biphenyl-4-yl) propan-1-ones as safer antiinflammatory and analgesic agents","volume":"44","author":"Husain","year":"2009","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109353_bb0200","doi-asserted-by":"crossref","first-page":"634","DOI":"10.4103\/0250-474X.100237","article-title":"Synthesis and evaluation of antiinflammatory, analgesic and ulcerogenic potential of NSAIDs bearing 1, 3, 4-oxadiazole scaffold","volume":"73","author":"Somani","year":"2011","journal-title":"Ind. J. Pharm. Sci."},{"key":"10.1016\/j.bioorg.2025.109353_bb0205","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.ejmech.2004.02.008","article-title":"Synthesis and anti-inflammatory, analgesic, ulcerogenic and lipid peroxidation activities of some new 2-[(2, 6-dichloroanilino) phenyl] acetic acid derivatives","volume":"39","author":"Amir","year":"2004","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109353_bb0210","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1111\/j.1476-5381.2011.01692.x","article-title":"A novel compound PTIQ protects the nigral dopaminergic neurones in an animal model of Parkinson's disease induced by MPTP","volume":"165","author":"Son","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bioorg.2025.109353_bb0215","doi-asserted-by":"crossref","first-page":"400","DOI":"10.3109\/08923973.2015.1070173","article-title":"Synthesis, toxicity study and anti-inflammatory effect of MHTP, a new tetrahydroisoquinoline alkaloid","volume":"37","author":"Pacheco de Oliveira","year":"2015","journal-title":"Immunopharm. Immunotox."},{"key":"10.1016\/j.bioorg.2025.109353_bb0220","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1007\/s10059-013-0078-x","article-title":"(S)-tetrahydroisoquinoline alkaloid inhibits LPS-induced arachidonic acid release through downregulation of cPLA 2 expression","volume":"36","author":"Choi","year":"2013","journal-title":"Mol. Cells"},{"key":"10.1016\/j.bioorg.2025.109353_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.113004","article-title":"Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment","volume":"211","author":"Zhang","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109353_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107577","article-title":"Design, synthesis and anti-inflammatory assessment of certain substituted 1, 2, 4-triazoles bearing tetrahydroisoquinoline scaffold as COX 1\/2-inhibitors","volume":"150","author":"Abo-Elmagd","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.109353_bb0235","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1080\/14756366.2018.1499628","article-title":"Novel thiazolidinone-containing compounds, without the well-known sulphonamide zinc-binding group acting as human carbonic anhydrase IX inhibitors","volume":"33","author":"G\u00fczel-Akdemir","year":"2018","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109353_bb0240","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.bbalip.2014.07.008","article-title":"Prostaglandin E2-induced inflammation: relevance of prostaglandin E receptors","volume":"1851","author":"Kawahara","year":"2015","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.bioorg.2025.109353_bb0245","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.641734","article-title":"Role of interleukin-6 in vascular health and disease","volume":"8","author":"Villar-Fincheira","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.bioorg.2025.109353_bb0250","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/1097-0029(20000801)50:3<184::AID-JEMT2>3.0.CO;2-H","article-title":"TNF\u03b1 and the TNF receptor superfamily: structure-function relationship (s)","volume":"50","author":"Idriss","year":"2000","journal-title":"Microsc. Res. Tech."},{"key":"10.1016\/j.bioorg.2025.109353_bb0255","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.bioorg.2017.09.018","article-title":"Novel quinoline incorporating 1, 2, 4-triazole\/oxime hybrids: synthesis, molecular docking, anti-inflammatory, COX inhibition, ulceroginicity and histopathological investigations","volume":"75","author":"Mohassab","year":"2017","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.109353_bb0260","series-title":"Theory and practice of histological techniques, 6th ed., Elsevier health sciences","author":"Bancroft","year":"2008"},{"key":"10.1016\/j.bioorg.2025.109353_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116155","article-title":"Hybrids of selective COX-2 inhibitors and active derivatives of edaravone as COX-2 selective NSAIDs with free radical scavenging activity: design, synthesis and biological activities","volume":"266","author":"Wang","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109353_bb0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107372","article-title":"Discovery of new 2-(3-(naphthalen-2-yl)-4, 5-dihydro-1H-pyrazol-1-yl) thiazole derivatives with potential analgesic and anti-inflammatory activities: in vitro, in vivo and in silico investigations","volume":"147","author":"Mohammed","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.109353_bb0275","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1021\/jm0613166","article-title":"Structural and functional basis of cyclooxygenase inhibition","volume":"50","author":"Blobaum","year":"2007","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109353_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107727","article-title":"Novel anti-inflammatory agents featuring phenoxy acetic acid moiety as a pharmacophore for selective COX-2 inhibitors: synthesis, biological evaluation, histopathological examination and molecular modeling investigation","volume":"152","author":"Elgohary","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.109353_bb0285","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3390\/molecules21020201","article-title":"Design, synthesis, and biological evaluation of some novel pyrrolizine derivatives as COX inhibitors with anti-inflammatory\/analgesic activities and low ulcerogenic liability","volume":"21","author":"Gouda","year":"2016","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2025.109353_bb0290","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1021\/ci6004299","article-title":"Validation studies of the site-directed docking program LibDock","volume":"47","author":"Rao","year":"2007","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.bioorg.2025.109353_bb0295","first-page":"553","article-title":"Synthesis and molecular docking of new imidazoquinazolinones as analgesic agents and selective COX-2 inhibitors, future","volume":"9","author":"Hassanein","year":"2017","journal-title":"Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109353_bb0300","doi-asserted-by":"crossref","first-page":"4613","DOI":"10.1016\/j.bmc.2004.06.038","article-title":"Synthesis, acute toxicities, and antitumor effects of novel 9-substituted \u03b2-carboline derivatives","volume":"12","author":"Cao","year":"2004","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109353_bb0305","doi-asserted-by":"crossref","first-page":"42717","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2025.109353_bb0310","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s00044-023-03166-z","article-title":"Design and synthesis of novel cycloalkanecarboxamide parabanic acid hybrids as anticonvulsants","volume":"33","author":"Abd-Allah","year":"2024","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.bioorg.2025.109353_bb0315","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1504\/IJCBDD.2013.052195","article-title":"Analysing molecular polar surface descriptors to predict blood-brain barrier permeation","volume":"6","author":"Shityakov","year":"2013","journal-title":"Int. J. Comput. Biol. Drug Des."},{"key":"10.1016\/j.bioorg.2025.109353_bb0320","doi-asserted-by":"crossref","first-page":"W513","DOI":"10.1093\/nar\/gkae303","article-title":"ProTox 3.0: a webserver for the prediction of toxicity of chemicals","volume":"52","author":"Banerjee","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bioorg.2025.109353_bb0325","doi-asserted-by":"crossref","first-page":"W422","DOI":"10.1093\/nar\/gkae236","article-title":"ADMETlab 3.0: an updated comprehensive online ADMET prediction platform enhanced with broader coverage, improved performance, API functionality and decision support","volume":"52","author":"Fu","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bioorg.2025.109353_bb0330","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.bmcl.2018.01.059","article-title":"New 4-aryl-1, 3, 2-oxathiazolylium-5-olates: chemical synthesis and photochemical stability of a novel series of S-nitrosothiols","volume":"28","author":"Eilertsen","year":"2018","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2025.109353_bb0335","first-page":"610","article-title":"Organic synthesis","volume":"3","author":"Weissberger","year":"1955","journal-title":"Coll"},{"key":"10.1016\/j.bioorg.2025.109353_bb0340","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1002\/jhet.5570420720","article-title":"The synthesis of 4-acylamino-1, 2, 4-triazole derivatives in the reaction of \u03b1-hydroxyacid hydrazidesand orthoesters","volume":"42","author":"Zieli\u0144ski","year":"2005","journal-title":"J. Heter. Chem."},{"key":"10.1016\/j.bioorg.2025.109353_bb0345","doi-asserted-by":"crossref","first-page":"1800269","DOI":"10.1002\/ardp.201800269","article-title":"Synthesis, molecular modeling studies, and anticonvulsant evaluation of novel 1-((2-hydroxyethyl)(aryl) amino)-N-substituted cycloalkanecarboxamides and their acetate esters","volume":"351","author":"Aboul-Enein","year":"2018","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.bioorg.2025.109353_bb0350","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0022-3565(25)26625-3","article-title":"Anti-inflammatory and antipyretic activities of indo-methacin, 1-(p-chlorobenzoyl)-5-methoxy-2-methyl-indole-3-acetic acid","volume":"141","author":"Winter","year":"1963","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bioorg.2025.109353_bb0355","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.3109\/13880209.2015.1078383","article-title":"Assessment of anti-inflammatory, antinociceptive, immunomodulatory, and antioxidant activities of Cajanus cajan L. seeds cultivated in Egypt and its phytochemical composition","volume":"54","author":"Hassan","year":"2016","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.bioorg.2025.109353_bb0360","first-page":"84","article-title":"Evaluation of anti-nociceptive and anti-inflammatory activities of Erythropleum ivorense stem bark in experimental animals, European J. Biomed","volume":"3","author":"Wakeel","year":"2016","journal-title":"Pharm. Sci"},{"key":"10.1016\/j.bioorg.2025.109353_bb0365","doi-asserted-by":"crossref","first-page":"326","DOI":"10.34172\/PS.2020.101","article-title":"Anti-inflammatory and analgesic activities of 7-Chloro-4-(Piperazin-1-yl) Quinoline derivative mediated by suppression of InflammatoryMediators expression in both RAW 264.7 and mouse models","volume":"27","author":"Aboutabl","year":"2020","journal-title":"Pharm. Sci."},{"key":"10.1016\/j.bioorg.2025.109353_bb0370","doi-asserted-by":"crossref","first-page":"196","DOI":"10.4103\/1687-4315.172877","article-title":"Analgesic and anti-inflammatory activities of certain 6-aryl-9-substituted-6, 9-diazaspiro-[4, 5] decane-8, 10-diones in mice","volume":"14","author":"Aboutabl","year":"2015","journal-title":"Egypt. Pharm. J."},{"key":"10.1016\/j.bioorg.2025.109353_bb0375","first-page":"517","article-title":"Red beet Peel-loaded liposome's impact on metabolic syndrome rats and its use as fortifier in yoghurt powder","volume":"66","author":"Alshafei","year":"2023","journal-title":"Egypt. J. Chem."},{"key":"10.1016\/j.bioorg.2025.109353_bb0380","doi-asserted-by":"crossref","DOI":"10.1002\/bmc.5352","article-title":"In vitro wound healing properties, antioxidant activities, HPLC\u2013ESI\u2013MS\/MS profile and phytoconstituents of the stem aqueous methanolic extract of Dracaena reflexa lam","volume":"36","author":"Raslan","year":"2022","journal-title":"Biomed. Chromatogr."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825012337?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825012337?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T02:05:23Z","timestamp":1768442723000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206825012337"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":76,"alternative-id":["S0045206825012337"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.109353","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design and synthesis of new 1,3,4-oxadiazole-1,2,3,4-tetrahydroisoquinoline hybrids as selective COX-2 inhibitors","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.109353","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109353"}}